Livermore, Calif.-based Halt Medical tacked an additional $5 million onto a third round of financing — now totaling $17 million — to test a device that can remove uterine fibroids without a hysterectomy. The contribution came from American Capital Strategies, according to VentureWire.
Halt conducted clinical trials in Latin America earlier this year, but expects to kick off a new series of tests in the U.S. by February 2009. Its other investors include William Richter, cofounder of Cerberus Capital Management, and Paul Volcker, former chairman of the Federal Reserve.
See more information on the device here.